- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/05 - Epstein-Barr virus
Patent holdings for IPC class C07K 14/05
Total number of patents in this class: 196
10-year publication summary
|
6
|
9
|
7
|
11
|
8
|
16
|
12
|
6
|
17
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2882 |
7 |
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | 373 |
6 |
| National Research Council of Canada | 1552 |
5 |
| The General Hospital Corporation | 4781 |
4 |
| City of Hope | 1001 |
4 |
| Dana-Farber Cancer Institute, Inc. | 2600 |
4 |
| Centre National de La Recherche Scientifique | 10576 |
3 |
| Glaxosmithkline Biologicals S.A. | 1651 |
3 |
| Baylor College of Medicine | 963 |
3 |
| Cancer Research Technology Limited | 526 |
3 |
| Cornell University | 3342 |
3 |
| The Council of the Queensland Institute of Medical Research | 158 |
3 |
| Deutsches Krebsforschungszentrum | 418 |
3 |
| Les Hopitaux Universitaires de Geneve | 40 |
3 |
| Universite de Geneve | 233 |
3 |
| Tusk Therapeutics Ltd | 31 |
3 |
| Sanofi | 4098 |
3 |
| Amgen Inc. | 4118 |
2 |
| The Board of Trustees of the Leland Stanford Junior University | 6487 |
2 |
| Wisconsin Alumni Research Foundation | 3887 |
2 |
| Other owners | 127 |